» Articles » PMID: 2400935

Vagal Afferent-mediated Inhibition of a Nociceptive Reflex by Intravenous Serotonin in the Rat. I. Characterization

Overview
Journal Brain Res
Specialty Neurology
Date 1990 Jul 30
PMID 2400935
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

The effect of intravenous (i.v.) serotonin (5-HT) on nociception and blood pressure was examined in male Sprague-Dawley rats. Intravenous 5-HT produced a dose-dependent (6-192 micrograms/kg, i.v.) inhibition of the nociceptive tail-flick (TF) reflex in lightly pentobarbital-anesthetized (ED50 = 40 micrograms/kg) and conscious rats (ED50 = 44 micrograms/kg). In the lightly pentobarbital-anesthetized rat, the blood pressure response to i.v. 5-HT was typically a triphasic response with a marked Bezold-Jarisch reflex-induced decrease in pressure (associated with a brief period of apnea) followed by a pressor phase and a subsequent delayed hypotension. In the conscious rat, the response was typically biphasic with the late hypotensive phase absent. A variety of anatomical and pharmacological manipulations were performed to characterize the 5-HT-induced inhibition of the TF reflex and associated changes in blood pressure. Prevention of 5-HT-induced reflex apnea by artificial ventilation did not affect inhibition of the TF reflex produced by 5-HT. Pharmacological manipulations were performed to mimic, as closely as possible, the acute increases and decreases in blood pressure associated with i.v. 5-HT. Nitroprusside (8 micrograms/kg, i.v.) produced a decrease in blood pressure of similar magnitude and rate as that associated with the Bezold-Jarisch reflex-induced decrease in pressure produced by 72 micrograms/kg 5-HT, but did not change TF latency from baseline. Similarly, acute increases in pressure produced by phenylephrine (8 micrograms/kg, i.v.), intended to mimic the secondary pressor effect of 5-HT, did not change TF latency. The short-acting ganglion blocker trimethaphan (5 mg/kg, i.v.) closely mimicked the late hypotensive phase produced by 5-HT, but again resulted in no change in TF latency. Pretreatment with the ganglion blocker chlorisondamine (2.5 mg/kg) abolished all depressor responses to 72 micrograms/kg 5-HT, but did not significantly affect the TF reflex. These results indicate that acute changes in blood pressure and respiration associated with i.v. 5-HT do not contribute to inhibition of the TF reflex. This conclusion was confirmed in experiments in which bilateral vagotomy abolished approximately 70% of the 5-HT-induced inhibition of the TF reflex (and all depressor responses), and resulted in a significantly greater pressor response. Finally, low thoracic spinal cord transection (T9-10) abolished the inhibition of the TF reflex produced by i.v. 5-HT. Therefore, 5-HT stimulates vagal afferents and inhibits the TF reflex by activating descending inhibitory systems from the brainstem.(ABSTRACT TRUNCATED AT 400 WORDS)

Citing Articles

A systematic review on descending serotonergic projections and modulation of spinal nociception in chronic neuropathic pain and after spinal cord stimulation.

Heijmans L, Mons M, Joosten E Mol Pain. 2021; 17:17448069211043965.

PMID: 34662215 PMC: 8527581. DOI: 10.1177/17448069211043965.


Transcutaneous auricular VNS applied to experimental pain: A paired behavioral and EEG study using thermonociceptive CO2 laser.

Dumoulin M, Liberati G, Mouraux A, Santos S, El Tahry R PLoS One. 2021; 16(7):e0254480.

PMID: 34252124 PMC: 8274876. DOI: 10.1371/journal.pone.0254480.


Review of the Uses of Vagal Nerve Stimulation in Chronic Pain Management.

Chakravarthy K, Chaudhry H, Williams K, Christo P Curr Pain Headache Rep. 2015; 19(12):54.

PMID: 26493698 DOI: 10.1007/s11916-015-0528-6.


Serotonin enhances urinary bladder nociceptive processing via a 5-HT3 receptor mechanism.

Hall J, DeWitte C, Ness T, Robbins M Neurosci Lett. 2015; 604:97-102.

PMID: 26247537 PMC: 4774045. DOI: 10.1016/j.neulet.2015.07.048.


Study of the in vivo and in vitro cardiovascular effects of (+)-glaucine and N-carbethoxysecoglaucine in rats.

Orallo F, Fernandez Alzueta A, Campos-Toimil M, Calleja J Br J Pharmacol. 1995; 114(7):1419-27.

PMID: 7606346 PMC: 1510273. DOI: 10.1111/j.1476-5381.1995.tb13364.x.